Paul Watkins

Howard Q. Ferguson Distinguished Professor; Director, Institute for Drug Safety Sciences
Eshelman School of Pharmacy, Univeristy of North Carolina
Chapel Hill, North Carolina, United States

Presentation(s):

• OC 40.3 - Hepatobiliary events in the fitusiran clinical development program with the revised AT-based dose regimen

  Monday, June 24, 2024
  15:15 – 15:30 ICT